Dutch AI Startup Whispp secures €750k in seed funding,Inevsted from angel investors and Leiden University holding Libertatis Ergo Holding BV (LEH), with additional investment coming from LUMO Labs as the primary investor.
With the use of Whispp’s real-time assistive voice technology and calling software, people with speech impairments from ALS, throat cancer, stuttering, and vocal cord paralysis can restore their natural voice. An estimated 300 million individuals worldwide are impacted by this.
Owing to modifications in the speech mechanism caused by neurological abnormalities, it can be beneficial to intentionally direct the voice towards whispering in many speaking disorders. When whispering, those with severe stuttering can cut their stuttering frequency by an average of 85%.
Whispp Founder and CEO Joris Castermans said, “Our big bold dream is to have Whispp’s assistive voice technology available on every smartphone and laptop worldwide to create a more inclusive world, To make this happen, we need and want to partner with mobile network operators and the largest technology companies in the world. We are confident that LUMO’s vast experience and valuable network will boost our growth.”
Sven Bakkes, Founding Partner at LUMO Labs said, “It is always special to meet a founder who has turned their own struggles and obstacles into innovative and groundbreaking solutions for others, We are deeply impressed with the tenacity, creativity and positive mindset of Joris and his co-founder Akash and are much looking forward to working with them going forward.”
The most recent investment round for Whispp, which was founded in 2019, comes after a pre-seed round in 2022 that was headed by Libertatis Ergo Holding B.V., a separate, fully-owned subsidiary of Leiden University. The new funding will be used by the creators to introduce their first calling app that is paid and subscription-based, as well as their assisted voice technology.